reports
Inogen to Report First Quarter 2024 Financial Results on May 7, 2024
GOLETA, Calif.--(BUSINESS WIRE)-- (Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report first quarter 2024 financial results after the market closes on Tuesday, May 7, 2024. On the same day, the Company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET. Individuals interested in listening to the conference call may do so by dialing: US domestic callers (877) 841-3961 Non-US callers (201) 689-8589 Please reference Inogen to join the call. A live audio webcast and archived recording o...
Ebix Reports Conclusion of SEC Investigation and Dismissal of All Pend...
Ebix Reports Conclusion of SEC Investigation and Dismissal of All Pending Securities Claims Against Ebix and its Officers in United States District Court for the Southern District of New York (SDNY) JOHNS CREEK, Ga., April 01, 2024 (GLOBE NEWSWIRE) -- Ebix, Inc. (OTC: EBIXQ) a leading international supplier of On-Demand software and E-commerce services to the insurance, financial, healthcare, and e-learning industries, announced today that the Securities and Exchange Commission (SEC) has concluded its investigation of Ebix and officially communicated that it does not intend to recommend a...
Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference
GOLETA, Calif.--(BUSINESS WIRE)-- (Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced management will participate in the 23rd Annual Needham Virtual Healthcare Conference. Kevin Smith, President and Chief Executive Officer, and Michael Bourque, Chief Financial Officer, are scheduled to participate in a fireside chat on Tuesday, April 9, 2024, at 9:30 a.m. Eastern Time. A live audio webcast and archived recording of the presentation will be available to all interested parties through the page on the Inogen web...
Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(...
GOLETA, Calif.--(BUSINESS WIRE)-- . (Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that, effective March 4, 2024, the Compensation Committee of Inogen’s Board of Directors approved awards of restricted stock units as material inducement to Michael Bourque entering into employment with the company to serve as its Executive Vice President, Chief Financial Officer and Treasurer. The equity awards were approved in accordance with NASDAQ Listing Rule 5635(c)(4), which also requires a public announcement of equity aw...
Wix.Com Ltd: 1 director
A director at Wix.Com Ltd sold 3,000 shares at 134.220USD and the significance rating of the trade was 78/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results
GOLETA, Calif.--(BUSINESS WIRE)-- . (Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter and the full-year ended December 31, 2023. “I am excited for the future of Inogen. As we progress into 2024, we are focused on positioning the business for revenue growth and long-term profitability while advancing our innovation pipeline and working to bring Physio-Assist to the U.S. market,” said Kevin Smith, President and Chief Executive Officer. “We have a strong management team with...
Inogen to Report Fourth Quarter and Full Year 2023 Financial Results o...
GOLETA, Calif.--(BUSINESS WIRE)-- (Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report fourth quarter and full year 2023 financial results after the market closes on Tuesday, February 27, 2024. On the same day, the Company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET. Individuals interested in listening to the conference call may do so by dialing: US domestic callers (877) 841-3961 Non-US callers (201) 689-8589 Please reference Inogen to join the call. To listen to a live webc...
Inogen Names Michael Bourque as New Chief Financial Officer
GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Michael Bourque as Chief Financial Officer, effective March 4, 2024. Mr. Bourque has served as Treasurer and Chief Financial Officer of Chase Corporation (formally NYSE:CCF) now owned by KKR & Co. Inc. He succeeds Interim Chief Financial Officer Mike Sergesketter, who will remain in an advisory role during the transition. Mr. Bourque has served as Chief Financial Officer and Treasurer of Chase ...
EbixCash Payment Solutions Reports Exceptional Year-over-Year Revenue ...
EbixCash Payment Solutions Reports Exceptional Year-over-Year Revenue and Income Growth in Q4 2023 and Full Year of 2023 Retains Dominant Leadership Role in Foreign Exchange, Inward and Education Money Remittance SectorsAddition of five international airports with presence now across 25 international airports.Launches UPI Handle to Facilitate Seamless Digital Transactions countrywide NOIDA, India, Jan. 08, 2024 (GLOBE NEWSWIRE) -- EbixCash Limited, a subsidiary of Ebix, Inc. (OTC: EBIXQ), a leading international supplier of On-Demand software and E-commerce services to the insurance, fin...
Ebix Annuity Exchange Closes 2023 with Record Annual Volumes of $118 B...
Ebix Annuity Exchange Closes 2023 with Record Annual Volumes of $118 Billion Record Numbers Reported Both in December 2023 and Q4 of 2023 JOHNS CREEK, Ga., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Ebix, Inc. (OTC: EBIXQ), a leading international supplier of On-Demand software and E-commerce services to the insurance, financial, healthcare, and e-learning industries, announced today that its Annuity Exchange AN4 has reported record volumes in the last quarter of 2023, besides reporting a record performance for the full year of 2023. Ebix’s AN4 Annuity exchange is an integral key part of Ebix’s...
Ebix Announces Q3 2023 Results
Ebix Announces Q3 2023 Results JOHNS CREEK, Ga., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of on-demand software and e-commerce services to the insurance, financial services, travel, healthcare, and e-learning industries today announced the following results for the quarter ended September 30, 2023: Q3 2023 GAAP Revenues of $119.2 million, with 1.1% Year-over-Year decline vs. Q3 2022 Non-GAAP Revenues of $120.5 million (with all revenues normalized on a net basis). On a GAAP basis, Q3 2022 revenues were $257.9 million (with pre-paid car...
Inogen Announces Leadership Change with the Appointment of Kevin Smith...
GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that its Board of Directors has appointed Kevin Smith as Inogen’s President and Chief Executive Officer and a member of the Board of Directors, effective immediately, succeeding Nabil Shabshab. Mr. Smith brings more than 20 years of commercial leadership experience in the medical device industry, including respiratory care and durable medical equipment businesses, and a history of success in executing value-creat...
Inogen to Present at Upcoming Investor Conferences in November 2023
GOLETA, Calif.--(BUSINESS WIRE)-- (Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will present at the following investor conferences: Stifel 2023 Healthcare Conference on Wednesday, November 15 at 10:20 a.m. Eastern Time Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29 at 10:30 a.m. Eastern Time A live webcast and archived recording of each presentation will be available to all interested parties through the page on the Inogen website. Inogen has used, and i...
Inogen Announces Third Quarter 2023 Financial Results
GOLETA, Calif.--(BUSINESS WIRE)-- (Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended September 30, 2023. Third Quarter 2023 and Recent Business Highlights Reported total revenue of $84.0 million, reflecting a decrease of 20.3% from the third quarter of 2022. Completed acquisition of Physio-Assist SAS, expanding Inogen’s global respiratory care presence by addressing a sizeable, growing, and underserved airway clearance market opportunity. “We have continued to im...
Inogen to Report Third Quarter 2023 Financial Results on November 7, 2...
GOLETA, Calif.--(BUSINESS WIRE)-- (Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report third quarter 2023 financial results after the market closes on Tuesday, November 7, 2023. On the same day, the Company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET. Individuals interested in listening to the conference call may do so by dialing: US domestic callers (877) 841-3961 Non-US callers (201) 689-8589 Please reference Inogen to join the call. To listen to a live webcast, please visi...
Ebix Signs Agreement with Lenders Regarding Credit Facility
Ebix Signs Agreement with Lenders Regarding Credit Facility JOHNS CREEK, Ga., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of On-Demand software and E-commerce services to the insurance, financial, healthcare, and e-learning industries, announced that it has signed an agreement with its Lenders, providing for a further period until November 15, 2023 for repayment of certain obligations under its Credit Facility, subject to certain conditions, while the Company pursues strategic alternatives. The Agreement mandates that by October 31, 2023 ...
Inogen Completes Acquisition of Physio-Assist
GOLETA, Calif.--(BUSINESS WIRE)-- (Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced it has completed the acquisition of Physio-Assist SAS, expanding the company’s innovative respiratory portfolio. Simeox, from Physio-Assist, is a technology-enabled airway clearance and mucus management device predominantly aimed at treating bronchiectasis which is a condition that presents as the lung’s bronchi are damaged and widened, in patients with cystic fibrosis or chronic obstructive pulmonary disease. Simeox is used in ...
Inogen Announces CFO Transition Plan
GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Mike Sergesketter as Interim Chief Financial Officer, effective immediately. Mr. Sergesketter last served as Interim Chief Financial Officer of the company between December 2021 and March 2022, and previously served as CFO of Kimball Electronics, Inc. where he was instrumental in helping to develop and execute the company’s globalization strategy while also building a robust finance function to s...
Ebix Announces Q2 2023 Results
Ebix Announces Q2 2023 Results JOHNS CREEK, Ga., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of on-demand software and e-commerce services to the insurance, financial services, travel, healthcare, and e-learning industries today announced the following results for the quarter ended June 30, 2023: Q2 2023 Revenues of $118.4 million, with 3.1% Year-over-Year growth vs. Q2 2022 Non-GAAP Revenues of $114.9 million (with all revenues normalized on a net basis). On a GAAP basis, Q2 2022 revenues were $242.7 million (with pre-paid card revenues ...
Inogen Recognized as a Finalist for Ragan's CSR & Diversity Awards Pro...
GOLETA, Calif.--(BUSINESS WIRE)-- (Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that it has been selected as a finalist in the Diversity, Equity & Inclusion Commitment Category for Ragan's . This recognition celebrates the outstanding efforts of organizations that have demonstrated exemplary commitment to corporate social responsibility and fostering diversity and inclusion within their communities and workplaces. The winners of Ragan's CSR & Diversity Awards will be announced during a on September 28, 202...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.